Drug Store News #jobs #in #pharmaceutical #companies

Posted On Apr 23 2017 by

#pharmacy industry news # The offices of Drug Store News will be closed for the Labor Day holiday weekend. We will resume publishing on Sept. 6. The Drug Store News team wishes you and your family a happy holiday! The multi-year contract, beginning in October, includes distribution of key product categories tailored specifically to fit the needs of Fred s unique format of a discount retailer and pharmacy. Walmart has unveiled its annual top toy list, chosen by hundreds of kids. Costco reported a 2% increase in same store sales for August and net sales of $8.9 billion. At its …


James T O – Donnell – James J O – Donnell #nature #s #pharma

Posted On Apr 23 2017 by

#pharma consultant # Consultations in Pharmacology, Pharmacy, Toxicology, Chemistry Nutrition Drug Injury, drug testing and interpretation, Alcohol testing and effects James Thomas O’Donnell, Pharm.D. M.S. FCP, ABCP, FACN, R.Ph.. is a pharmacologist, pharmacist and nutritionist. His career has included pharmacy practice in a variety of settings, as well as teaching, research, publications, and consultations in pharmacology, pharmacy, and nutrition to industry, government, health care, publishing and legal fields. He is Associate Professor of Pharmacology at the Rush University Medical Center in Chicago, where he served as the Course Director for the Medical Pharmacology program. He also held Faculty appointments at …


Pharmaceutical information #ranbaxy #pharma

Posted On Apr 23 2017 by

#pharmaceutical information # Erelzi Erelzi (etanercept-szzs) is a tumor necrosis factor (TNF) blocker biosimilar to Enbrel indicated for the treatment of rheumatoid arthritis. Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent, narcotic analgesic formulation. Sustol Sustol (granisetron) is a long-acting 5-HT3 antagonist indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV). Drugs in Development (Not yet approved) Ingrezza Ingrezza (valbenazine) is a novel, highly-selective VMAT2 inhibitor in development for the treatment of tardive dyskinesia. brigatinib Brigatinib is an investigational anaplastic lymphoma kinase (ALK) inhibitor in development for the treatment of patients with anaplastic. Radicava …


Par Pharmaceutical #exl #pharma

Posted On Apr 23 2017 by

#pharmaceutical products # The development and growth of the generic pharmaceutical industry over the past 30 years has come as a response to rising healthcare costs. Generic pharmaceuticals, which are carefully manufactured formulations of the original, patented “brand name” products, help to make American healthcare more affordable. For more information on generic drugs, visit the FDA’s Office of Generic Drugs webpage. Answer. Yes, Generic pharmaceutical manufacturers must provide to the FDA that their version of the drug: contains the same active ingredient; is identical in strength, dosage form, and route of administration; has the same indications, dosing, and labeling; and …


2013 so far: the pharmaceutical products making headway in the UK #app #pharma

Posted On Apr 23 2017 by

#pharmaceutical products # The pharmaceutical products set to make headway in the UK market, 2013 In the last few decades it s been widely reported that the UK s contribution to new pharmaceutical products has steadily declined overall, but last year broke the trend with a record-breaking 39 projects approved. The biggest slump in relatively recent times was in 1985 when only 11 new products went to market, and activity peaked in 1997 and again in 2010 with 34 product launches respectively. A detailed description of activity can be found here. This year, a new wave of medicines to treat …


The Top 50 Global Pharma Companies 2014 #pharma #sales #jobs

Posted On Apr 23 2017 by

#top 50 pharmaceutical companies # The Top 50 Global Pharma Companies 2014 The Pharmaceutical Executive magazine publishes its annual ranking of the Top 50 Pharma Companies Worldwide based on sales in the previous year. This year s list was released back in June. The Top 50 Global Pharma Companies are listed in the tables below: Click to enlarge Here are a few observations: Swiss drug giant Novartis(NVS ) replaced last year s topper Pfizer (PFE ). Novartis beats Pfizer in R D expenditure as well. The top 10 firms are either from the U.S. or developed Europe. It is not …


KV Pharma – Pharma manufacturing consent decrees #small #pharma #companies

Posted On Apr 23 2017 by

#kv pharma # KV Pharma – Pharma manufacturing consent decrees Product recalls involving oversized tablets and other causes, which followed FDA discovery of manufacturing problems in a 2008 inspection, ultimately led to this far-reaching consent decree. It stretches beyond KV to subsidiaries Ther-Rx and ETHEX, all three of which were forced to stop manufacturing and distribution operations due to adulteration and, for some drugs, lack of market approval. ETHEX, ultimately, was shuttered. The regulator enlisted the help of U.S. Marshalls, who seized more than $24 million in products following KV’s continued production after the FDA-ordered halt. KV hired GMP expert …


Catalyst Pharma Consulting #pharmacy #news

Posted On Apr 23 2017 by

#pharma consultant # Catalyst Pharma Consulting is a Mumbai (India) based international team of Consultants providing a wide range of consulting services to Pharmaceutical, Biotechnology and Active Pharmaceutical Ingredients (APIs) Industry. This team of professionals is well positioned to help you identify and enhance business opportunities in the rapidly growing Indian market. Recipient of several awards, and covered in ‘Who’s Who in the World’, Devinder Pal has played a key role in enhancing the status of Indian Pharmaceutical Industry and the standing of the profession of Pharmacy, in recognition of which he was awarded Eminent Pharmacist Award 2003 the highest …


Pharmaceutical Industry Overview of Global companies #pharmaceutical #industry #analysis

Posted On Apr 23 2017 by

#pharmaceutical industry overview # Industry Overview Indian Pharmaceutical Industry Indian pharmaceutical market is among the top five emerging pharmaceutical markets in the world According to McKinsey Company report (“India Pharma 2015”), the following trends influence the growth of the Indian pharmaceuticals market: Doubling of disposable incomes and the number of middle-class households Expansion of medical infrastructure Greater penetration of health insurance Rising prevalence of chronic diseases Adoption of product patents Aggressive market penetration driven by the relatively smaller companies The revenue CAGR from 2009-2012 has been 12.4%, and is expected to increase to 14-17% between 2012-2016 This growth is expected …